• Exchange: BSE India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Saamya Biotech India Ltd

+ Add to Watchlist

SBIL:IN

2.51 INR 0.04 1.62%

As of 03:27:38 ET on 07/22/2014.

Snapshot for Saamya Biotech India Ltd (SBIL)

Open: 2.51 Day's Range: 2.51 - 2.51 Volume: 3,276
Previous Close: 2.47 52wk Range: 0.98 - 2.87 1-Yr Rtn: -1.18%

Stock Chart for SBIL

No chart data available.
  • SBIL:IN 2.51
  • 1D
  • 1M
  • 1Y
2.47
Interactive SBIL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SBIL

Current P/E Ratio (ttm) 65.7051
Estimated P/E(-) -
Relative P/E vs. SENSEX 3.6044
Earnings Per Share (ttm) 0.0382
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 62.46
Shares Outstanding (M) 24.88
30 Day Average Volume 15,802
Price/Book (mrq) 0.1816
Price/Sale (ttm) 0.4674
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SBIL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for SBIL

Saamya Biotech India Ltd. manufactures biopharmaceutical ingredients. The Company produces daunomycin and ophthalmic and cosmetic grade hyaluronic acid.

Y Sonia ReddyChairman/Joint Managing DirY Manivardhan ReddyManaging Director
Manne Bhavani ShankarCompliance Officer
More Company Profile & Key Executives for SBIL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil